You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for Patent: 9,296,756


✉ Email this page to a colleague

« Back to Dashboard


Title:Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same
Abstract: Stable crystalline forms of a compound represented by the formula (IA): ##STR00001## an acid addition salt, and/or a solvate thereof are provided by the present invention. Said crystalline forms are extremely useful as materials for preparing medicines. Novel processes for preparing 6,7-unsaturated-7-carbamoyl morphinan derivatives are also provided by the present invention.
Inventor(s): Inagaki; Masanao (Toyonaka, JP), Morimoto; Kenji (Toyonaka, JP), Haga; Nobuhiro (Toyonaka, JP), Oda; Shinichi (Iwate-ken, JP)
Assignee: Shionogi & Co., Ltd. (Osaka, JP)
Filing Date:Aug 04, 2015
Application Number:14/818,152
Claims:1. A process for preparing a compound of the formula (II): ##STR00049## wherein R.sup.1b is a hydroxy-protecting group, R.sup.2 is optionally substituted lower alkyl, and R.sup.3 is optionally substituted lower alkyl, optionally substituted cycloalkyl, optionally substituted aryl or optionally substituted heteroaryl, comprising: reacting a compound of the formula (III): ##STR00050## wherein R.sup.1b and R.sup.2 is the same as defined above, in the presence or absence of an acid with a compound of the formula: R.sup.3--N.dbd.C.dbd.O, wherein R.sup.3 is the same as defined above, or with a compound of the formula: R.sup.3--NH--C(.dbd.O)--X, wherein R.sup.3 is the same as defined above and X is a leaving group.

2. The process according to claim 1, wherein the compound of the formula (III) is obtained by protecting hydroxyl of a compound of the formula (IV): ##STR00051## wherein R.sup.2 is the same as defined in claim 1.

3. The process according to claim 2, wherein after the compound of the formula (III) is obtained from the compound of the formula (IV); the compound of the formula (III) is reacted successively with the compound of the formula: R.sup.3--N.dbd.C.dbd.O, or with the compound of the formula: R.sup.3--NH--C(.dbd.O)--X in the presence or absence of an acid.

4. The process according to claim 1, wherein the reaction of the compound of the formula (III) with the compound of the formula: R.sup.3--N.dbd.C.dbd.O or the compound of the formula R.sup.3--NH--C(.dbd.O)--X is carried out in the presence of an acid.

5. The process according to claim 4, wherein the acid is a Lewis acid.

6. The process according to claim 5, wherein the Lewis acid is CuCl, CuCl.sub.2, CuBr, CuI, CuBr, CuSO.sub.4, Cu, Zn(OAc).sub.2, ZnBr.sub.2 or ZnCl.sub.2.

7. The process according to claim 4, wherein the acid is present in an amount about 0.00005-1.0 molar equivalents to the compound of the formula (III).

8. The process according to claim 1, wherein R.sup.1b is a hydroxyl-protective group deprotectable by a base.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.